evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract
18157,GENE_SUMMARY,,VEGFA encodes a homodimeric glycoprotein that can be essential component of tumor initiation as well as being the primary stimulus for angiogenesis. VEGFA is commonly over-expressed in many solid tumors.,,2017-04-17,,7422,VEGFA,vascular endothelial growth factor A,False,ENST00000523873,NM_001171623.1,MVCD1,VEGF,VPF,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
18158,GENE_BACKGROUND,,"VEGFA encodes vascular endothelial growth factor A, often referred to as VEGF. It is a member of a family of vascular endothelial growth factors (VEGFs) and platelet-derived growth factors (PDGFs). VEGFA signaling in tumor cells is mediated by the receptor tyrosine kinases VEGFR-1 and VEGFR-2, with almost all of the known cellular responses mediated by VEGFR-2 (PMID: 16951216). Other types of receptors contribute to VEGFA signaling including platelet-derived growth factor receptors (PMID: 17470632) and neuropilins (PMID: 22948112, 23116416). Autocrine VEGF signaling is generally characteristic of more aggressive cancers (PMID: 22693250) and has been shown to promote the function of cancer stem cells (PMID: 22012397, 20141840). VEGFA also affects the function of nearby immune cells (PMID: 23045606) and fibroblasts (PMID: 22738912) and may also act within tumor cells to regulate survival (PMID: 21057529). VEGFA is an oncogene commonly over-expressed in many solid tumors. Both somatic and germline mutations are known but it is not commonly mutated in any cancer type (cBioPortal, MSKCC, Mar. 2016). Germline polymorphisms in VEGFA have been associated with recurrent depressive disorder development (PMID: 23673188). Bevacizumab (PMID: 17212999) and aflibercept (PMID: 22446028) are VEGFA inhibitors FDA-approved for metastatic colorectal cancer.",,2017-04-17,,7422,VEGFA,vascular endothelial growth factor A,False,ENST00000523873,NM_001171623.1,MVCD1,VEGF,VPF,False,22012397,A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours.,Nature,2018-10-19T20:11:00,478,7369,399-403,Beck B et al,doi: 10.1038/nature10525,,2018-10-19T04:03:00,,22446028,Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug.,The British journal of ophthalmology,2018-09-01T20:12:00,96,9,1157-8,Stewart MW,doi: 10.1136/bjophthalmol-2011-300654,,0001-09-01,,23045606,Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth.,The Journal of experimental medicine,2018-10-22T20:12:00,209,11,2001-16,Hansen W et al,doi: 10.1084/jem.20111497,,0001-10-22,,23116416,Function of members of the neuropilin family as essential pleiotropic cell surface receptors.,Biochemistry,2017-11-27T20:12:00,51,47,9437-46,Parker MW et al,doi: 10.1021/bi3012143,,0001-11-27,,22693250,VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression.,Cancer research,2018-08-15T20:12:00,72,16,3912-8,Cao Y et al,doi: 10.1158/0008-5472.CAN-11-4058,,0001-08-15,,22738912,Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment.,Cancer research,2018-08-15T20:12:00,72,16,4047-59,Yaqoob U et al,doi: 10.1158/0008-5472.CAN-11-3907,,0001-08-15,,22948112,"Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity.",Oncotarget,2018-09-01T20:12:00,3,9,921-39,Prud'homme GJ et al,,,0001-09-01,,21057529,Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells.,Oncogene,2018-03-10T20:11:00,30,10,1205-12,Samuel S et al,doi: 10.1038/onc.2010.496,,0001-03-10,,23673188,0001-05-01,Progress in neuro-psychopharmacology &amp; biological psychiatry,2018-08-01T20:13:00,45,,117-24,Ga≈Çecki P et al,doi: 10.1016/j.pnpbp.2013.04.011,,0001-08-01,,17470632,Vascular endothelial growth factor can signal through platelet-derived growth factor receptors.,The Journal of cell biology,2018-05-07T20:07:00,177,3,489-500,Ball SG et al,,,2018-05-07T05:00:00,,16951216,Vascular endothelial growth factor signaling pathways: therapeutic perspective.,Clinical cancer research : an official journal of the American Association for Cancer Research,2018-09-01T20:06:00,12,17,5018-22,Kowanetz M et al,,,0001-09-01,,17212999,Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.,Clinical therapeutics,2018-11-01T20:06:00,28,11,1779-802,Shih T et al,,,2018-11-01T08:02:00,,20141840,Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development.,Cell,2018-01-22T20:10:00,140,2,268-79,Lichtenberger BM et al,doi: 10.1016/j.cell.2009.12.046,,0001-01-22,
